Consonance Capital

Consonance Capital

Consonance Capital Partners (“CCP”) is a private equity manager focused exclusively on investing in the healthcare industry. CCP’s founders, Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities (collectively “JPMP”), and have over 90 years of combined experience in private equity investing, primarily within healthcare. To date, CCP has raised over $1.3 billion in equity capital across two funds, and CCP is currently investing out of Consonance Private Equity II, L.P. CCP targets growth equity, leveraged buyouts, and recapitalization transactions in the middle market. Target companies generally have between $25 million and $500 million in revenues. With a history of successfully investing across multiple healthcare sub-sectors, Consonance Capital Partners brings a wealth of experience, insights, and an extensive network of relationships to existing and prospective management teams and portfolio companies.